SUVRETTA CAPITAL MANAGEMENT, LLC 13D and 13G filings for Whitehawk Therapeutics Inc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-11 7:22 pm Purchase | 2025-03-04 | 13G | Whitehawk Therapeutics Inc WHWK | SUVRETTA CAPITAL MANAGEMENT, LLC | 4,727,510 9.990% | 4,727,510 (New Position) | Filing |